Five teams of Central Intercollegiate Athletic Association athletes hit the water and scaled walls as part of their training in April at the U.S. Navy SEALs’ Little Creek Naval Amphibious Base in Virginia Beach, Va.
Chowan University, St. Paul’s College, Bowie State University, St. Augustine’s College and Virginia State University players all got a taste of the rigors of training with the SEALs in a 12-foot-deep, Olympic-size pool and on the Naval Special Warfare Group 2 Confidence Course, a 17-station land obstacle course.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/lubearcorp/50063/
Following their dramatic victory in the 137th Kentucky Derby on Saturday, the connections of Animal Kingdom were presented with The Longines Column-Wheel Chronograph, the official watch of the Kentucky Derby at the event’s exclusive Winners’ Circle Gala.
Owner Barry Irwin, trainer Graham Motion and jockey Johnny Velazquez received the watches from Jennifer Judkins, U.S. Brand President for Longines, the Official Watch and Timekeeper of the Kentucky Derby and Churchill Downs.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/longines/49667/
Roland Corporation U.S. and Girl Scouts of the USA have announced a Chicago stop on Saturday, May 14 and a New York City stop on May 21st, in conjunction with the national tour of the new Girl Scouts Rock! Initiative, which includes workshops designed to inspire and empower girls through music.
Girl Scouts Rock! Powered by Roland will reach thousands of Girl Scouts and their parents across the country, delivering the message that you can have a “Better Life with Music.” The fun, interactive curriculum co-developed by Roland and Girl Scouts of the USA gets girls pumped up about making music and music education. Girl Scouts Rock! is designed to provide girls ages 8-14 with a hands-on experience playing popular music, an opportunity fewer girls are receiving due to school music budget cuts.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/girlscoutsrock/46002/
As many as one in five U.S. teens suffers from disabling mental illness. Throughout Mental Health Awareness Month in May, BeSmartBeWell.com highlights the issue of mental illness in teens and tells the stories of two teens who moved from diagnosis through treatment and recovery.
What does mental illness look like in teens? It looks like Colleen, who’s battled depression and anxiety since she was 13, and Katie, who struggled with addiction in her early teens. Mental illness in teens looks just like the kid next door – studies show nearly half of all youth will experience a mental disorder at some point in their lives.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/besmartbewell/50033/
U.S. President Barack Obama will receive the warmest of Irish welcomes when he visits the Emerald Isle this week. Hundreds of thousands of well wishers will line the streets as the President makes his first visit to Ireland - home to some of his ancestors. Mr. Obama’s heritage has been traced to the village of Moneygall in Co, Offaly. There is a great sense of pride in this tiny picturesque village located at the very center of the island, where preparations are in full swing.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/tourismireland/50368/
Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, has announced the first nine U.S. cities for a series of evening events to introduce clinicians to the Selenia Dimensions 2D/3D breast tomosynthesis system and gain hands-on experience with this new technology.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/hologic/50094/
TruGreen recently launched MyBotanicPlanet.com, a free online educator resource to inspire K-5 students’ interest in the diverse plant world, to receptive educators attending the National Science Teachers Association (NSTA) national conference in San Francisco. TruGreen, the nation’s largest professional lawn, tree and shrub care provider, is receiving high marks from educators for the brand’s creative resource that enables convenient access to U.S. standardized lesson plans in botany and related interactive activities.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/trugreen/50275/
Bayer HealthCare’s Consumer Care division announced today the introduction of Bayer® Advanced Aspirin, the next generation of aspirin for pain relief. Using the patent-pending Pro-Release™ Technology, Bayer Advanced Aspirin is clinically proven to relieve tough pain twice as fast as previous Bayer® Aspirin tablets.
With the introduction of aspirin in 1899, Bayer offered one of the first widely accessible analgesics, or pain relievers, to consumers. Today, Bayer's overall global Aspirin business continues to grow, and had double-digit, year-on-year sales growth in Q1 2011. Yet, while Bayer continues to be a leader in the category, for many U.S. consumers, Bayer Aspirin is primarily synonymous with cardiovascular use. Now, through a combination of technological innovation and rich analgesic heritage, Bayer is introducing a new standard in aspirin for tough pain relief with Bayer Advanced Aspirin.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/bayer/50414/
For juicy, tender and flavorful pork, it might be time to toss out Grandma’s advice. Announced today, new U.S. Department of Agriculture (USDA) guidelines confirm that 145 degrees Fahrenheit as measured on a food thermometer, followed by a three-minute rest time, is a safe final internal cooking temperature for pork.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/pork/50354/
Could migraine patients be doing more to get the most out of their medical visits? According to a new national survey released by the National Headache Foundation (NHF) and GlaxoSmithKline, the answer is yes. For the nearly 30 million migraine sufferers in the U.S., including six million treating with prescription medication, these survey results may have important implications.
The survey, conducted online in November 2010 by Harris Interactive, included 1,218 diagnosed migraine patients taking prescription medications for their migraine attacks as well as 533 physicians who treat between five and 10 migraine patients per week. The findings revealed disparities between what patients and physicians each reported typically discussing during office visits.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/glaxosmithkline/48596/
Six of 13 small cars recently evaluated by the Insurance Institute for Highway Safety earn the TOP SAFETY PICK award, and none earn a poor rating in any of 4 tests. This is a turnaround from a few years ago when small cars struggled to earn top safety ratings. The new tests include hybrids and gasoline-only models that are among the most fuel-efficient vehicles available in the U.S. market.
The ratings are based on performance in front, side, rollover, and rear impact evaluations. Cars that earn the top rating of good in each test and have available electronic stability control (ESC) qualify for TOP SAFETY PICK. Winners are the 2012 Ford Focus and Honda Civic, along with the 2011 Hyundai Elantra, Lexus CT 200h hybrid, Nissan Juke, and Toyota Prius hybrid. The Civic, CT 200h, Elantra, Focus, and Prius have at least one version with a government fuel economy rating of at least 40 miles per gallon on the highway. The Dodge Caliber, Honda CR-Z and Insight hybrids, Nissan Sentra and Versa, Scion xD, and Suzuki SX4 also were rated but didn’t earn TOP SAFETY PICK.
Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) announced today that the U.S. Food and Drug Administration (FDA) has approved the company’s antibacterial drug DIFICID™ (fidaxomicin) tablets for the treatment of Clostridium difficile-associated diarrhea (CDAD) in adults 18 years of age and older. CDAD is a significant medical problem in hospitals and long-term care facilities, and is beginning to emerge in the community among people previously at low risk for the disease. In the largest Phase 3 clinical studies ever conducted in CDAD, DIFICID had clinical response rates at the end of treatment that were non-inferior to oral vancomycin. DIFICID was superior to vancomycin in sustaining clinical response through 25 days beyond the end of treatment. DIFICID is the only FDA-approved antibacterial drug proven to be superior to vancomycin in sustained clinical response for CDAD.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/optimerpharma/50177/
